LifeStance Health (LFST) Receivables (2020 - 2026)

LifeStance Health (LFST) has 7 years of Receivables data on file, last reported at $122.9 million in Q1 2026.

• Receivables for Q1 2026 came in at $122.9 million, down 12.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $122.9 million (down 12.43% YoY), and the FY2025 annual result was $99.5 million, down 24.64% from the prior year.
• Receivables improved to $122.9 million in Q1 2026 per LFST's latest filing, from $99.5 million in the prior quarter.
• Over five years, Receivables peaked at $175.9 million in Q1 2024 and troughed at $95.0 million in Q1 2022.
• A 5-year average of $127.7 million and a median of $122.9 million in 2026 frame the typical range for Receivables.
• The sharpest annual moves came in 2022 and 2025: Receivables jumped 54.47% in 2022, then decreased 24.64% in 2025.
• A 5-year view of Receivables shows it stood at $101.5 million in 2022, then increased by 23.77% to $125.6 million in 2023, then rose by 5.08% to $132.0 million in 2024, then declined by 24.64% to $99.5 million in 2025, then increased by 23.53% to $122.9 million in 2026.
• Business Quant data shows LFST's Receivables at $122.9 million in Q1 2026, $99.5 million in Q4 2025, and $121.1 million in Q3 2025.